Name | KTX-612 |
---|
Description | KTX-612 is an orally active IRAK4 degrader with a DC50 value of 7 nM. KTX-612 can be used for the research of oncology[1]. |
---|---|
Related Catalog | |
Target |
IRAK4:7 nM (DC50) |
In Vitro | KTX-612 has activity for IRAK4 with a DC50 value of 7 nM[1]. |
In Vivo | KTX-612 (oral; 10 mg/kg) impacts oral absorption[1]. Animal Model: Rat[1] Dosage: 10 mg/kg Administration: Oral Result: Rat PO PK (10 mg/kg) KTX-612 %F 1 AUC(μM*hr) 0.060 |
References |
Molecular Formula | C46H51F3N8O6 |
---|---|
Molecular Weight | 868.94 |